You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Impact of pharmacist intervention on the utilization of sitagliptin use in the ckd
- In: Poster presentation
- At: Seoul (South Korea) (2017)
- Type: Poster
- Poster code: POS-HPS-077
- By: LEE, Chi-Hui (China Taiwan)
- Co-author(s): Chi-Hui Lee
- Abstract:
Background
Sitagliptin is the first DPP-IV inhibitor and studies have demonstrated that appropriate reductions dose in chronic kidney disease (CKD) patients.Purpose
This study was to evaluate the impacts of pharmacist intervention on sitagliptin utilization in chronic kidney disease .Methods
This study was divided into three periods of repetitive.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026